Nasdaq · Common stock
Xeris Biopharma Holdings (XERS)
$10.21 +$0.01 (+0.10%)
- Day’s range
- $10.12–$10.41
- Volume
- 1.9M
XERS price history
XERS closed at $10.21 on Oct. 26, 2026. Over the past year, its daily close ranged from $5.29 on March 24, 2026 to $11.13 on Oct. 20, 2026.
Data table: XERS daily closes, the past year
| Date | Close |
|---|---|
| Oct. 26, 2026 | $10.21 |
| Oct. 23, 2026 | $10.20 |
| Oct. 22, 2026 | $10.86 |
| Oct. 21, 2026 | $10.79 |
| Oct. 20, 2026 | $11.13 |
| Oct. 19, 2026 | $10.95 |
| Oct. 16, 2026 | $10.31 |
| Oct. 15, 2026 | $10.07 |
| Oct. 14, 2026 | $9.77 |
| Oct. 13, 2026 | $10.20 |
| Oct. 12, 2026 | $10.46 |
| Oct. 9, 2026 | $10.48 |
| Oct. 8, 2026 | $10.19 |
| Oct. 7, 2026 | $10.11 |
| Oct. 6, 2026 | $10.07 |
| Oct. 5, 2026 | $10.13 |
| Oct. 2, 2026 | $9.08 |
| Oct. 1, 2026 | $9.25 |
| Sept. 30, 2026 | $9.56 |
| Sept. 29, 2026 | $9.98 |
| Sept. 28, 2026 | $9.83 |
| Sept. 25, 2026 | $9.10 |
| Sept. 24, 2026 | $8.95 |
| Sept. 23, 2026 | $8.66 |
| Sept. 22, 2026 | $8.73 |
| Sept. 21, 2026 | $8.80 |
| Sept. 18, 2026 | $8.20 |
| Sept. 17, 2026 | $8.16 |
| Sept. 16, 2026 | $7.78 |
| Sept. 15, 2026 | $7.49 |
| Sept. 14, 2026 | $7.57 |
| Sept. 11, 2026 | $7.45 |
| Sept. 10, 2026 | $7.67 |
| Sept. 9, 2026 | $7.71 |
| Sept. 8, 2026 | $8.48 |
| Sept. 4, 2026 | $8.53 |
| Sept. 3, 2026 | $8.59 |
| Sept. 2, 2026 | $8.58 |
| Sept. 1, 2026 | $8.43 |
| Aug. 31, 2026 | $8.44 |
| Aug. 28, 2026 | $8.48 |
| Aug. 27, 2026 | $8.60 |
| Aug. 26, 2026 | $8.68 |
| Aug. 25, 2026 | $8.74 |
| Aug. 24, 2026 | $8.74 |
| Aug. 21, 2026 | $8.70 |
| Aug. 20, 2026 | $8.60 |
| Aug. 19, 2026 | $8.78 |
| Aug. 18, 2026 | $8.85 |
| Aug. 17, 2026 | $8.52 |
| Aug. 14, 2026 | $8.60 |
| Aug. 13, 2026 | $8.33 |
| Aug. 12, 2026 | $8.49 |
| Aug. 11, 2026 | $8.39 |
| Aug. 10, 2026 | $7.99 |
| Aug. 7, 2026 | $7.93 |
| Aug. 6, 2026 | $7.36 |
| Aug. 5, 2026 | $8.11 |
| Aug. 4, 2026 | $8.19 |
| Aug. 3, 2026 | $8.13 |
| July 31, 2026 | $8.08 |
| July 30, 2026 | $8.42 |
| July 29, 2026 | $8.38 |
| July 28, 2026 | $8.24 |
| July 27, 2026 | $8.21 |
| July 24, 2026 | $8.32 |
| July 23, 2026 | $8.41 |
| July 22, 2026 | $8.38 |
| July 21, 2026 | $8.78 |
| July 20, 2026 | $8.60 |
| July 17, 2026 | $8.80 |
| July 16, 2026 | $8.69 |
| July 15, 2026 | $8.70 |
| July 14, 2026 | $8.28 |
| July 13, 2026 | $8.16 |
| July 10, 2026 | $8.34 |
| July 9, 2026 | $8.62 |
| July 8, 2026 | $8.67 |
| July 7, 2026 | $8.94 |
| July 6, 2026 | $8.37 |
| July 2, 2026 | $8.28 |
| July 1, 2026 | $8.00 |
| June 30, 2026 | $7.92 |
| June 29, 2026 | $7.74 |
| June 26, 2026 | $7.69 |
| June 25, 2026 | $7.40 |
| June 24, 2026 | $7.40 |
| June 23, 2026 | $7.20 |
| June 22, 2026 | $6.90 |
| June 18, 2026 | $6.95 |
| June 17, 2026 | $6.90 |
| June 16, 2026 | $6.90 |
| June 15, 2026 | $6.88 |
| June 12, 2026 | $6.79 |
| June 11, 2026 | $6.93 |
| June 10, 2026 | $6.71 |
| June 9, 2026 | $6.50 |
| June 8, 2026 | $6.24 |
| June 5, 2026 | $6.18 |
| June 4, 2026 | $6.15 |
| June 3, 2026 | $5.89 |
| June 2, 2026 | $6.00 |
| June 1, 2026 | $6.07 |
| May 29, 2026 | $6.16 |
| May 28, 2026 | $6.32 |
| May 27, 2026 | $6.23 |
| May 26, 2026 | $6.26 |
| May 22, 2026 | $6.19 |
| May 21, 2026 | $6.38 |
| May 20, 2026 | $6.23 |
| May 19, 2026 | $5.92 |
| May 18, 2026 | $6.01 |
| May 15, 2026 | $6.24 |
| May 14, 2026 | $6.38 |
| May 13, 2026 | $6.43 |
| May 12, 2026 | $6.26 |
| May 11, 2026 | $6.14 |
| May 8, 2026 | $6.53 |
| May 7, 2026 | $6.63 |
| May 6, 2026 | $6.37 |
| May 5, 2026 | $6.23 |
| May 4, 2026 | $6.34 |
| May 1, 2026 | $6.28 |
| April 30, 2026 | $6.13 |
| April 29, 2026 | $6.02 |
| April 28, 2026 | $6.09 |
| April 27, 2026 | $6.12 |
| April 24, 2026 | $6.05 |
| April 23, 2026 | $5.95 |
| April 22, 2026 | $6.04 |
| April 21, 2026 | $5.89 |
| April 20, 2026 | $6.25 |
| April 17, 2026 | $6.37 |
| April 16, 2026 | $6.12 |
| April 15, 2026 | $6.20 |
| April 14, 2026 | $6.07 |
| April 13, 2026 | $5.97 |
| April 10, 2026 | $5.85 |
| April 9, 2026 | $6.01 |
| April 8, 2026 | $5.92 |
| April 7, 2026 | $5.87 |
| April 6, 2026 | $6.05 |
| April 2, 2026 | $6.04 |
| April 1, 2026 | $6.04 |
| March 31, 2026 | $5.80 |
| March 30, 2026 | $5.60 |
| March 27, 2026 | $5.40 |
| March 26, 2026 | $5.57 |
| March 25, 2026 | $5.30 |
| March 24, 2026 | $5.29 |
| March 23, 2026 | $5.61 |
| March 20, 2026 | $5.44 |
| March 19, 2026 | $5.58 |
| March 18, 2026 | $5.43 |
| March 17, 2026 | $5.61 |
| March 16, 2026 | $5.49 |
| March 13, 2026 | $5.46 |
| March 12, 2026 | $5.48 |
| March 11, 2026 | $5.73 |
| March 10, 2026 | $5.82 |
| March 9, 2026 | $5.60 |
| March 6, 2026 | $5.81 |
| March 5, 2026 | $6.04 |
| March 4, 2026 | $6.07 |
| March 3, 2026 | $5.94 |
| March 2, 2026 | $6.02 |
| Feb. 27, 2026 | $6.12 |
| Feb. 26, 2026 | $6.74 |
| Feb. 25, 2026 | $6.66 |
| Feb. 24, 2026 | $6.68 |
| Feb. 23, 2026 | $6.58 |
| Feb. 20, 2026 | $6.61 |
| Feb. 19, 2026 | $6.73 |
| Feb. 18, 2026 | $7.03 |
| Feb. 17, 2026 | $6.91 |
| Feb. 13, 2026 | $6.82 |
| Feb. 12, 2026 | $6.91 |
| Feb. 11, 2026 | $6.91 |
| Feb. 10, 2026 | $7.22 |
| Feb. 9, 2026 | $6.96 |
| Feb. 6, 2026 | $7.01 |
| Feb. 5, 2026 | $6.91 |
| Feb. 4, 2026 | $7.08 |
| Feb. 3, 2026 | $7.34 |
| Feb. 2, 2026 | $7.36 |
| Jan. 30, 2026 | $7.36 |
| Jan. 29, 2026 | $7.24 |
| Jan. 28, 2026 | $7.16 |
| Jan. 27, 2026 | $7.51 |
| Jan. 26, 2026 | $7.48 |
| Jan. 23, 2026 | $7.44 |
| Jan. 22, 2026 | $7.61 |
| Jan. 21, 2026 | $7.62 |
| Jan. 20, 2026 | $7.61 |
| Jan. 16, 2026 | $7.52 |
| Jan. 15, 2026 | $7.41 |
| Jan. 14, 2026 | $7.58 |
| Jan. 13, 2026 | $7.71 |
| Jan. 12, 2026 | $7.87 |
| Jan. 9, 2026 | $7.93 |
| Jan. 8, 2026 | $8.13 |
| Jan. 7, 2026 | $7.21 |
| Jan. 6, 2026 | $6.96 |
| Jan. 5, 2026 | $7.09 |
| Jan. 2, 2026 | $7.35 |
| Dec. 31, 2025 | $7.85 |
| Dec. 30, 2025 | $7.31 |
| Dec. 29, 2025 | $7.43 |
| Dec. 26, 2025 | $7.37 |
| Dec. 24, 2025 | $7.21 |
| Dec. 23, 2025 | $7.28 |
| Dec. 22, 2025 | $7.21 |
| Dec. 19, 2025 | $7.34 |
| Dec. 18, 2025 | $7.01 |
| Dec. 17, 2025 | $6.99 |
| Dec. 16, 2025 | $7.10 |
| Dec. 15, 2025 | $7.05 |
| Dec. 12, 2025 | $7.17 |
| Dec. 11, 2025 | $7.01 |
| Dec. 10, 2025 | $6.94 |
| Dec. 9, 2025 | $7.01 |
| Dec. 8, 2025 | $6.99 |
| Dec. 5, 2025 | $6.51 |
| Dec. 4, 2025 | $6.72 |
| Dec. 3, 2025 | $6.73 |
| Dec. 2, 2025 | $6.47 |
| Dec. 1, 2025 | $6.96 |
| Nov. 28, 2025 | $7.18 |
| Nov. 26, 2025 | $7.18 |
| Nov. 25, 2025 | $7.10 |
| Nov. 24, 2025 | $7.04 |
| Nov. 21, 2025 | $6.83 |
| Nov. 20, 2025 | $6.84 |
| Nov. 19, 2025 | $7.09 |
| Nov. 18, 2025 | $7.08 |
| Nov. 17, 2025 | $7.26 |
| Nov. 14, 2025 | $7.18 |
| Nov. 13, 2025 | $7.26 |
| Nov. 12, 2025 | $7.59 |
| Nov. 11, 2025 | $7.44 |
| Nov. 10, 2025 | $7.72 |
| Nov. 7, 2025 | $7.43 |
| Nov. 6, 2025 | $7.71 |
| Nov. 5, 2025 | $9.87 |
| Nov. 4, 2025 | $9.90 |
| Nov. 3, 2025 | $9.90 |
| Oct. 31, 2025 | $9.70 |
| Oct. 30, 2025 | $9.71 |
| Oct. 29, 2025 | $9.62 |
| Oct. 28, 2025 | $9.23 |
| Oct. 27, 2025 | $9.31 |
Key figures
- 52-week range
- $5.29–$11.13Low March 24, 2026; high Oct. 20, 2026
- Average daily volume
- 2.3MPast 3 months
- Market value
- $1.86B
- Dividend yield
- —
- From 52-week high
- −8.27%
Price change
- 1 month
- +12.20%
- 3 months
- +22.72%
- Year to date
- +30.06%
- 1 year
- +10.86%
$1,000 a year ago
$1,000 put into XERS at the close on Oct. 24, 2025 would be worth $1,109.
Price only, dividends not included.
What Wall Street says about XERS
In the past 90 days, Wall Street firms published 3 rating or price-target actions on XERS: 3 raised price targets.
| Action | Rating | |||
|---|---|---|---|---|
| Barclays | Raises target | Overweight | $12 to $14 | |
| Leerink Partners | Raises target | Outperform | $12 to $16 | |
| Barclays | Raises target | Overweight | $9 to $12 |
Ratings and price targets are the firms’ own opinions, reported as published.
Not investment advice.
About Xeris Biopharma Holdings, Inc. Common Stock
Xeris Biopharma Holdings Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offers Recorlev for the treatment of endogenous hypercortisolemia in patients with Cushing's syndrome; Gvoke for the treatment of severe hypoglycemia; and Keveyis for the treatment of Primary Periodic Paralysis (PPP). Additionally, the company is advancing its Phase 3-ready pipeline product, XP-8121, a once-weekly subcutaneous injection of levothyroxine, which leverages its proprietary technology, XeriSol.
- Headquarters
- Chicago, Ill.
- Employees
- 435
- Listed
- June 21, 2018
- Sector
- Health care
- Industry
- Pharmaceutical preparations
In WallStreetDigest editions
No WallStreetDigest article about XERS is on the site yet.